Additionally, animal models of tauopathies have shown that apoE4 is associated with greater total tau and phospho-tau levels [102], and exacerbates tau-mediated neurodegeneration by modulating microglial activation [103, 104]. This evidence concerns the gene MAPT and tauopathy.